Oritavancin Use in Patients with Recurrent Bone Infections by Methicillin-Resistant Staphylococcus aureus and Role of Therapeutic Drug Monitoring
2 Mins
Oritavancin is a novel long-acting lipoglycopeptide that is active against gram-positive micro-organisms, including…
